TradingView
warrenhochfeld
3. Jan. 2018 12:25

Achaogen Rebound Likely In 2018-Long Long

NASDAQ:AKAO180

Beschreibung

⋅
Expected rebound ahead of the 25 June FDA action date for Plazomicin for the Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
Trend AnalysisBeyond Technical Analysis
Mehr